Feldon
Steven Feldon, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20080231803 | COMPACT OCULAR FUNDUS CAMERA - Embodiments of a compact camera for imaging the ocular fundus are described. In some embodiments, the camera is a light, handheld camera that acquires a plurality of images of the fundus. The camera can be configured to acquire images manually or automatically. A movable imaging lens or movable image detector provides the images in a series to obtain an image with optimal focus. The camera can acquire a series of images and allow selection of an optimal image either manually, or automatically. In some embodiments, the camera is part of an imaging system that includes a base station. The base station exchanges data with the camera and can receive image data generated by the image detector of the camera. The base can further include networking capability, such that image data can be distributed over a network or to other communication or computing devices. | 09-25-2008 |
20120015001 | METHODS OF TREATING THYROID EYE DISEASE - The present invention relates to a methods and compositions for the treatment of and management of symptoms for thyroid eye disease. The methods include administering to a patient having thyroid eye disease an agent that interferes with hyaluronan synthesis in an amount that is effective to inhibit hyaluronan synthesis in a retro-ocular space. The pharmaceutical compositions hat includes a carrier suitable for ophthalmic delivery and an agent that interferes with hyaluronan synthesis. Combination therapies are also disclosed. | 01-19-2012 |
20130003016 | CALIBRATION DEVICE FOR USE WITH A FUNDUS CAMERA - A calibration device for use with a fundus camera is described, including a mock retina having a curvature from a front portion to a back portion. The calibration device further includes a color model having a range of colors comparable to a range of colors of the fundus of an eye. The calibration device further can include a lens for magnification and is configured to facilitate generation of an image to evaluate and adjust an ophthalmic imaging system for features such as color, magnification, and resolution. | 01-03-2013 |
Steven E. Feldon US
Patent application number | Description | Published |
---|---|---|
20150283205 | THY1 (CD90) AS A NOVEL THERAPY TO CONTROL ADIPOSE TISSUE ACCUMULATION - The present invention relates to methods of treating a condition involving excessive adipogenesis. This method relates to selecting a subject having a condition involving excessive adipogenesis and administering to the selected subject a composition comprising a Thy1 protein or polypeptide fragment thereof, or an agent that enhances Thy1 expression, under conditions effective to treat the condition. The present invention also relates to isolated nucleic acid molecules encoding a Thy1 protein or the fragment thereof and pharmaceutical formulations including such a protein or fragment thereof or an agent that enhances Thy1 expression and a pharmaceutically acceptable carrier. The present invention also relates to methods of inhibiting adipogenesis and/or decreasing adipocyte size, as well as methods of screening a candidate compound for its ability to influence adipogenesis. | 10-08-2015 |
Steven E. Feldon, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20150283205 | THY1 (CD90) AS A NOVEL THERAPY TO CONTROL ADIPOSE TISSUE ACCUMULATION - The present invention relates to methods of treating a condition involving excessive adipogenesis. This method relates to selecting a subject having a condition involving excessive adipogenesis and administering to the selected subject a composition comprising a Thy1 protein or polypeptide fragment thereof, or an agent that enhances Thy1 expression, under conditions effective to treat the condition. The present invention also relates to isolated nucleic acid molecules encoding a Thy1 protein or the fragment thereof and pharmaceutical formulations including such a protein or fragment thereof or an agent that enhances Thy1 expression and a pharmaceutically acceptable carrier. The present invention also relates to methods of inhibiting adipogenesis and/or decreasing adipocyte size, as well as methods of screening a candidate compound for its ability to influence adipogenesis. | 10-08-2015 |